Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells

American Journal of Physiology - Renal Physiology

Volumn 281, Issue 4 50-4, 2001, Pages

  Lieberthal, Wilfred ^a,e   Fuhro, Robert ^a   Andry, C Christopher ^b   Rennke, Helmut ^c   Abernathy, Vivian E ^a   Koh, Jason S ^a   Valeri, Robert ^b   Levine, Jerrold S ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Department of Obstetrics and Gynecology   (United States)

^e BOSTON UNIVERSITY   (United States)

Author keywords

70 kDa S6 protein kinase; Ischemia; Proliferation

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 2; RAPAMYCIN; S6 KINASE;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL LOSS; CELL REGENERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; IC 50; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0034789534     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.281.4.f693     Document Type: Article

References (51)

1. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
2. Nephrotoxicity of immunosuppressive drugs: Experimental and clinical observations
3. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506
4. Chronic cyclosporine nephropathy in renal transplanation
5. Risk factors for acute renal failure requiring dialysis after liver transplantation
6. The role of IGFs in catabolism
7. The 70kDa S6 kinase: Regulation of a kinase with multiple roles in mitogenic signalling
8. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases
9. Specificity and mechanism of action of some commonly used protein kinase inhibitors
10. Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis
11. Mechanisms of action of the immunopressant rapamycin
12. Prevention of ischemic injury in renal transplantation
13. Differential effects of insulin-like growth factor 1 (IGF-1) and IGF-binding protein-1 on protein metabolism in human skeletal muscle cells
14. The serine protease inhibitors, tosylphenylalanine chloromethyl ketone and tosyllysine chloromethyl ketone, potently inhibit pp70s6k activation
15. Potential role of growth factors in the prophylaxis and treatment of acute renal failure
16. Therapeutic use of growth factors in renal failure
17. Growth factors and cytokines in acute renal failure
18. Acute renal failure: Growth factors, cell therapy, gene therapy
19. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway
20. Functional and cytoskeletal changes induced by sublethal injury in proximal tubular epithelial cells
21. 1 progression
22. Lysophosphatidic acid: A novel growth and survival factor for renal proximal tubular cells
23. Effects of hemoglobin-based oxygen-carrying solutions in anesthetized rats with acute ischemic renal failure
24. O-raffinose crosslinking markedly reduces the systemic and renal vasoconstrictor effects of unmodified human hemoglobin
25. Necrosis and apoptosis in acute renal failure
26. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury
27. Graded ATP depletion can induce apoptosis or necrosis of cultured mouse proximal tubular cells
28. Role of superoxide in apoptosis induced by growth factor withdrawal
29. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis
30. Impairments in both p70 S6 kinase and extracellular signal-regulated kinase signaling pathways contribute to the decline in proliferative capacity of aged hepatocytes
31. Inhibition of the immune response by rapamycin, a new antifungal antibiotic
32. Mechanisms causing loss of muscle in acute uremia
33. 1/S-phase growth arrest in T lymphocytes
34. Rapamycin inhibition of interleukin-2-dependent p 33cdk2 and p34cdc2 kinase activation in T lymphocytes
35. Rapid colorimetric assay for cell growth and survival: Application to proliferation and cytotoxicity assays
36. Increased membrane permeability of apoptotic thymocytes: A flow cytometric study
37. Discordant effects of rapamycin on proliferation and p70S6 kinase phosphorylation in normal and neoplastic rat chromaffin cells
38. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase
39. Social controls on cell survival and cell death
40. Renal mouse proximal tubular cells are more susceptible than MDCK cells to chemical anoxia
41. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro
42. A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes
43. + thymocytes by flow cytometry
44. Regeneration after acute tubular necrosis
45. Sirolimus: A new agent for prevention of renal allograft rejection
46. Constitutive expression of the machinery for programmed cell death
47. Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies
48. Localization of proliferating cell nuclear antigen, vimentin, c-fos and clusterin in postischemic kidney. Evidence for a heterogeneous genetic response among nephron segments and a large pool of mitotically active and dedifferentiated cells
49. Acute renal failure in the setting of bone marrow transplantation
50. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis